share_log

Pfizer | DEFA14A: Others

SEC announcement ·  Apr 9 22:34
Summary by Futu AI
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as a vote reminder. This filing, identified as DEFA14A, is part of the Schedule 14A Proxy Statement, which is required under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Pfizer as the registrant, indicating that the company is directly involved in the solicitation of proxies from shareholders. No filing fee was required for this submission. The purpose of these materials is to remind shareholders to vote, an important aspect of corporate governance and shareholder engagement.
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as a vote reminder. This filing, identified as DEFA14A, is part of the Schedule 14A Proxy Statement, which is required under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Pfizer as the registrant, indicating that the company is directly involved in the solicitation of proxies from shareholders. No filing fee was required for this submission. The purpose of these materials is to remind shareholders to vote, an important aspect of corporate governance and shareholder engagement.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.